Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Dy

P2.15-24 Comparison of Pemetrexed Administered Q 3 Weeks vs Q 4 Weeks as Maintenance Therapy in NSCLC: Analysis of Real World Data From a Single Institution

Journal of Thoracic Oncology

English

P3.01-86 Treatment Outcomes With Reduced Frequency of Nivolumab Dosing as Second-Line Therapy in Patients With Advanced NSCLC

Journal of Thoracic Oncology

English

Related publications

Real World Data and the Art of Maintenance Therapy

British Journal of Haematology

Hematology

2018

English

Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study

Bone Marrow Transplantation

Transplantation

Hematology

2008

English

Two Weeks as a Chemist

Open Schools Journal for Open Science

2019

English

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

English

Prognostic Value of a Single Exercise Test 3 Weeks After Uncomplicated Myocardial Infarction

Circulation

Cardiovascular Medicine

Physiology

Cardiology

1980

English

Development of Pre-Eclampsia Within 4 Weeks of sFlt-1/PlGF Ratio > 38: Comparison of Performance at 31-34vs35-37 Weeks' Gestation

Ultrasound in Obstetrics and Gynecology

Nuclear Medicine

Radiology

Ultrasound Technology

Gynecology

Reproductive Medicine

English

Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study

Annals of the Rheumatic Diseases

English

Pentaquark States With the $$QQQq\bar{q}$$ Q Q Q Q Q ¯ Configuration in a Simple Model

European Physical Journal C

English

The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People's Republic of China

ClinicoEconomics and Outcomes Research

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Dy

P2.15-24 Comparison of Pemetrexed Administered Q 3 Weeks vs Q 4 Weeks as Maintenance Therapy in NSCLC: Analysis of Real World Data From a Single Institution

P3.01-86 Treatment Outcomes With Reduced Frequency of Nivolumab Dosing as Second-Line Therapy in Patients With Advanced NSCLC

Related publications

Real World Data and the Art of Maintenance Therapy

Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study

Two Weeks as a Chemist

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Prognostic Value of a Single Exercise Test 3 Weeks After Uncomplicated Myocardial Infarction

Development of Pre-Eclampsia Within 4 Weeks of sFlt-1/PlGF Ratio > 38: Comparison of Performance at 31-34vs35-37 Weeks' Gestation

Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study

Pentaquark States With the $$QQQq\bar{q}$$ Q Q Q Q Q ¯ Configuration in a Simple Model

The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People&#39;s Republic of China

The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People's Republic of China